One in 10 Babies is Born Too Soon
With an incidence of one in ten pregnancies1, preterm birth is considered by medical experts to be a public health crisis. The emotional, financial, and long-term health implications for preterm babies and their families can be overwhelming. Up until this point, ways to accurately predict the risk of a preterm delivery have been limited, with only a small percentage of high-risk patients identified through clinical or demographic risk factors.
Determine your patient’s risk of spontaneous preterm birth, even if she lacks obvious risk factors
The PreTRM® Test provides physicians with their patients’ risk for spontaneous premature birth in asymptomatic singleton pregnancies. This pivotal information — provided in the form of an individual risk percentage — gives you time and vital insights to make informed treatment decisions with your patients.
Up to half of all pregnant women who deliver prematurely have no known risk factors.2
The PreTRM® Test is Suitable for 88% of Singleton Pregnant Women3,4
PreTRM® Intended Use:
The PreTRM® Test for Risk Management predicts the risk of spontaneous preterm birth (before 37 weeks) in asymptomatic women (no signs or symptoms of preterm labor, with intact membranes) ≥18 years old with a singleton pregnancy. The PreTRM Test is performed via a single blood draw between 19wk/1d-20wk/6d (134-146 days) gestation. It is not intended for use in women who have a multiple pregnancy, have a known or suspected fetal anomaly, or are on any form of progesterone therapy after the first trimester.
Learn More About the PreTRM® Test
- Hamilton BE, et al. Births: Provisional data for 2020. Vital Statistics Rapid Release; no 12. Hyattsville, MD: National Center for Health Statistics. May 2021.
- Iams, JD. Clinical Practice. Prevention of preterm parturition. N Engl J Med. 2014;370:254-61.
- Petrini JR, et al. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol. 2005;105:267-72.
- Hassan SS, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind,
placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38:18-31.